SG11201808069VA - System and process for neuroprotective therapy for glaucoma - Google Patents
System and process for neuroprotective therapy for glaucomaInfo
- Publication number
- SG11201808069VA SG11201808069VA SG11201808069VA SG11201808069VA SG11201808069VA SG 11201808069V A SG11201808069V A SG 11201808069VA SG 11201808069V A SG11201808069V A SG 11201808069VA SG 11201808069V A SG11201808069V A SG 11201808069VA SG 11201808069V A SG11201808069V A SG 11201808069VA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- california
- retinal
- glaucoma
- ojai
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F2009/00861—Methods or devices for eye surgery using laser adapted for treatment at a particular location
- A61F2009/00863—Retina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F2009/00885—Methods or devices for eye surgery using laser for treating a particular disease
- A61F2009/00891—Glaucoma
Landscapes
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Optics & Photonics (AREA)
- Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Laser Surgery Devices (AREA)
- Radiation-Therapy Devices (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Eye Examination Apparatus (AREA)
- Prostheses (AREA)
Abstract
INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property 1111111111 011101010111110101111101110111110101110111111111011111011110111111 Organization International Bureau (10) International Publication Number (43) International Publication Date ......0\"\"1 WO 2017/192168 Al 09 November 2017 (09.11.2017) WIP0 I PCT (51) International Patent Classification: L.; 2879 MacArthur Blvd, Oakland, California 94602 (US). A61F 9/008 (2006.01) CHANG, David B.; 14212 Livingston, Tustin, California (21) International Application Number: 92780 (US). PCT/US2016/062421 (74) Agent: KELLEY, Scott W.; Kelly & Kelley, LLP, 6320 (22) International Filing Date: Canoga Avenue, Suite 1650, Woodland Hills, California 17 November 2016 (17.11.2016) 91367 (US). (25) Filing Language: English (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, (26) Publication Language: English AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, (30) Priority Data: CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, 15/148,842 06 May 2016 (06.05.2016) US DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, 15/188,608 21 June 2016 (21.06.2016) US HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KW, 15/232,320 09 August 2016 (09.08.2016) US KZ, LA, MN, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, (71) Applicant: OJAI RETINAL TECHNOLOGY, LLC PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, [US/US]; 283 Carne Road, Ojai, California 93023 (US). SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (72) Inventors: LUTTRULL, Jeffrey K.; 283 Carne Road, Ojai, California 93023 (US). MARGOLIS, Benjamin W. Title: SYSTEM AND PROCESS FOR NEUROPROTECTWE THERAPY FOR GLAUCOMA = (54) = = 18 1 = ----- -- - -- -, = — = / I 7 i 11 12 = = 22 , 1 1 11 • , 14 16 = 20 I I v • \ r = = = \:\ _ = 114i %'41.. ..--....—.../ = 18 IIIIIIIIIIII/ FIG. 1 ,-1 . 4 GC 1-1 (57) : Providing neuroprotective therapy for glaucoma includes generating a micropulsed laser light beam having parameters ei and characteristics, including pulse length, power, and duty cycle, selected to create a therapeutic effect with no visible laser lesions or ON tissue damage to the retina. The laser light beam is applied to retinal and/or foveal tissue of an eye having glaucoma or a risk of glaucoma 1-1 --.... to create a therapeutic effect to the retinal and/or foveal tissue exposed to the laser light beam without destroying or permanently IN damaging the retinal and/or foveal tissue and improve function or condition of 1-1 an optic nerve and/or retinal ganglion cells of the eye. 0 ei O [Continued on next page] WO 2017/192168 Al MIDEDIM1111011111111111111111111111111111111111111111111111011110111110111111111111 (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Published: — with international search report (Art. 21(3))
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/148,842 US10363171B2 (en) | 2012-05-25 | 2016-05-06 | System and process for retina phototherapy |
US15/188,608 US10238542B2 (en) | 2012-05-25 | 2016-06-21 | System and process for retina phototherapy |
US15/232,320 US9962291B2 (en) | 2012-05-25 | 2016-08-09 | System and process for neuroprotective therapy for glaucoma |
PCT/US2016/062421 WO2017192168A1 (en) | 2016-05-06 | 2016-11-17 | System and process for neuroprotective therapy for glaucoma |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201808069VA true SG11201808069VA (en) | 2018-11-29 |
Family
ID=60203181
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201808069VA SG11201808069VA (en) | 2016-05-06 | 2016-11-17 | System and process for neuroprotective therapy for glaucoma |
Country Status (9)
Country | Link |
---|---|
EP (2) | EP3451983B1 (en) |
JP (1) | JP2019514454A (en) |
CN (1) | CN109069294B (en) |
AU (1) | AU2016405579B2 (en) |
BR (1) | BR112018072711A2 (en) |
CA (1) | CA3018167A1 (en) |
ES (2) | ES2952701T3 (en) |
SG (1) | SG11201808069VA (en) |
WO (1) | WO2017192168A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110237432A (en) * | 2019-06-06 | 2019-09-17 | 中山大学中山眼科中心 | A method of increasing eyeground blood flow and metabolic rate |
CN110812145B (en) * | 2019-11-20 | 2022-02-22 | 精准视光(北京)医疗技术有限公司 | Visual function adjusting method and device and virtual reality head-mounted display equipment |
EP4171454A4 (en) * | 2020-06-24 | 2024-06-05 | Senogen GmbH | Systems, methods, and apparatus for ocular laser therapy |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5921981A (en) | 1995-11-09 | 1999-07-13 | Alcon Laboratories, Inc. | Multi-spot laser surgery |
US20030078567A1 (en) * | 2001-04-27 | 2003-04-24 | Giorgio Dorin | Method and apparatus for laser ThermoProtectiveTreatment(TPT) with pre-programmed variable irradiance long exposures |
CA2587522A1 (en) * | 2004-11-15 | 2006-05-26 | Christopher Decharms | Stimulation of neural tissue with light |
KR20080031474A (en) * | 2005-07-27 | 2008-04-08 | 유니버시티 오브 플로리다 리서치 파운데이션, 아이엔씨. | Use of heat shock to treat ocular disease |
DK2170232T3 (en) | 2007-05-30 | 2017-09-25 | Ellex R&D Pty Ltd | Laser for retinal rejuvenation |
WO2011050056A2 (en) * | 2009-10-20 | 2011-04-28 | Boston Biocom Llc | Laser treatment of eye diseases |
US10238541B2 (en) * | 2011-10-19 | 2019-03-26 | Iridex Corporation | Short duration pulse grid pattern laser treatment and methods |
EP2768378B1 (en) * | 2011-10-19 | 2021-12-22 | Iridex Corporation | Grid pattern laser treatments |
US9962291B2 (en) * | 2012-05-25 | 2018-05-08 | Ojai Retinal Technology, Llc | System and process for neuroprotective therapy for glaucoma |
US10219947B2 (en) * | 2012-05-25 | 2019-03-05 | Ojai Retinal Technology, Llc | System and process for retina phototherapy |
US9168174B2 (en) * | 2012-05-25 | 2015-10-27 | Ojai Retinal Technology, Llc | Process for restoring responsiveness to medication in tissue of living organisms |
EP2986245B1 (en) * | 2013-04-18 | 2024-07-24 | Iridex Corporation | Micropulse grid pattern laser treatment device |
JP6439271B2 (en) * | 2013-04-30 | 2018-12-19 | 株式会社ニデック | Laser therapy device |
-
2016
- 2016-11-17 CA CA3018167A patent/CA3018167A1/en active Pending
- 2016-11-17 EP EP16901155.8A patent/EP3451983B1/en active Active
- 2016-11-17 WO PCT/US2016/062421 patent/WO2017192168A1/en unknown
- 2016-11-17 JP JP2018548105A patent/JP2019514454A/en active Pending
- 2016-11-17 ES ES16901155T patent/ES2952701T3/en active Active
- 2016-11-17 ES ES19185801T patent/ES2951189T3/en active Active
- 2016-11-17 EP EP19185801.8A patent/EP3593771B1/en active Active
- 2016-11-17 SG SG11201808069VA patent/SG11201808069VA/en unknown
- 2016-11-17 CN CN201680085322.8A patent/CN109069294B/en active Active
- 2016-11-17 AU AU2016405579A patent/AU2016405579B2/en active Active
- 2016-11-17 BR BR112018072711-3A patent/BR112018072711A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ES2951189T3 (en) | 2023-10-18 |
AU2016405579B2 (en) | 2022-03-31 |
EP3593771C0 (en) | 2023-07-12 |
WO2017192168A1 (en) | 2017-11-09 |
EP3451983A4 (en) | 2019-10-23 |
BR112018072711A2 (en) | 2019-02-19 |
EP3451983A1 (en) | 2019-03-13 |
EP3451983C0 (en) | 2023-08-16 |
CN109069294B (en) | 2022-05-31 |
CN109069294A (en) | 2018-12-21 |
ES2952701T3 (en) | 2023-11-03 |
EP3593771B1 (en) | 2023-07-12 |
JP2019514454A (en) | 2019-06-06 |
EP3593771A1 (en) | 2020-01-15 |
EP3451983B1 (en) | 2023-08-16 |
CA3018167A1 (en) | 2017-11-09 |
AU2016405579A1 (en) | 2018-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201407205WA (en) | System and process for retina phototherapy | |
SG11201810034XA (en) | ANTI-cMet ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE | |
SG11201909096WA (en) | Systems and methods for ocular laser surgery and therapeutic treatments | |
SG11201909247UA (en) | Transcatherer atrial sealing skirt, anchor, and tether and methods of implantation | |
SG11201804814YA (en) | Materials and methods for delivering nucleic acids to cochlear and vestibular cells | |
SG11201910019PA (en) | Microorganisms and methods for producing cannabinoids and cannabinoid derivatives | |
SG11201810515TA (en) | Internal ultraviolet therapy | |
SG11201903946SA (en) | Devices and methods for slurry generation | |
SG11201811491YA (en) | Quinazoline and indole compounds to treat medical disorders | |
SG11201809809YA (en) | Electro-magnetic needle catheter insertion system | |
SG11201909303TA (en) | Point of delivery cold slurry generation | |
SG11201903520UA (en) | A tens device for activity monitoring, gait analysis, and balance assessment | |
SG11201909155VA (en) | Ask1 inhibitor compounds and uses thereof | |
SG11201811470PA (en) | Pyrazolopyrimidine derivatives as kinase inhibitor | |
SG11201808306PA (en) | Treatment of cancer with tg02 | |
SG11201810440VA (en) | Medical devices, systems and methods utilizing permanent magnet and magnetizable feature | |
SG11201408405WA (en) | Engineered three-dimensional connective tissue constructs and methods of making the same | |
SG11201804263PA (en) | Cancer treatment using 2-deoxy-2-fluoro-l-fucose in combination with a checkpoint inhibitor | |
SG11201900349VA (en) | Somatostatin modulators and uses thereof | |
SG11201903032SA (en) | Methods and compositions related to nk cell and anti-pdl1 cancer therapies | |
SG11201808713YA (en) | Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier | |
SG11201901063SA (en) | Therapeutic agents for neurodegenerative diseases | |
SG11201807041PA (en) | Improved preparations of adult liver progenitor cells | |
SG11201805381TA (en) | Electroporation device with detachable needle array with lock-out system | |
SG11201809875VA (en) | Compositions and methods for treating spinal muscular atrophy |